211 related articles for article (PubMed ID: 17626322)
1. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
[No Abstract] [Full Text] [Related]
2. Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis.
Colombet I; Bura-Rivière A; Chatila R; Chatellier G; Durieux P;
BMC Health Serv Res; 2004 Sep; 4(1):27. PubMed ID: 15456515
[TBL] [Abstract][Full Text] [Related]
3. Guidelines on oral anticoagulation with warfarin - fourth edition.
Keeling D; Baglin T; Tait C; Watson H; Perry D; Baglin C; Kitchen S; Makris M;
Br J Haematol; 2011 Aug; 154(3):311-24. PubMed ID: 21671894
[No Abstract] [Full Text] [Related]
4. Paradoxical venous limb gangrene complicating oral anticoagulation in a patient with cancer-associated deep venous thrombosis.
Georgin S; Pouchot J; Raschilas F; Barete S; Lerolle DL; Vinceneux P
Arch Dermatol; 2003 Sep; 139(9):1126-8. PubMed ID: 12975152
[No Abstract] [Full Text] [Related]
5. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Brotman DJ
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
[No Abstract] [Full Text] [Related]
6. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Glynn RJ
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
[No Abstract] [Full Text] [Related]
7. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
[No Abstract] [Full Text] [Related]
8. The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.
J Am Geriatr Soc; 2000 Feb; 48(2):224-7. PubMed ID: 10682955
[No Abstract] [Full Text] [Related]
9. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Malik V; Kupfer Y; Tessler S
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
[No Abstract] [Full Text] [Related]
10. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Tran HA
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
[No Abstract] [Full Text] [Related]
11. [Early and loud].
Schellong S
Vasa; 2003 May; 32(2):59-60. PubMed ID: 12945096
[No Abstract] [Full Text] [Related]
12. Control of long-term anticoagulant therapy.
Lawson DH; McDonald GA
Scott Med J; 1967 Apr; 12(4):163-5. PubMed ID: 6034271
[No Abstract] [Full Text] [Related]
13. Self-monitoring and self-management of anticoagulation therapy.
Cayley WE
Am Fam Physician; 2011 Aug; 84(3):266-8. PubMed ID: 21842772
[No Abstract] [Full Text] [Related]
14. [Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older].
Pautas É; Peyron I; Gouin-Thibault I; Gouronnec A; Monti A; Bouhadiba S; Badie C; Golmard JL; Siguret V
Rev Med Interne; 2015 Jan; 36(1):7-9. PubMed ID: 24373728
[TBL] [Abstract][Full Text] [Related]
15. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based initiation of warfarin (Coumadin).
Ebell MH
Am Fam Physician; 2005 Feb; 71(4):763-5. PubMed ID: 15742915
[No Abstract] [Full Text] [Related]
17. Evidence-based adjustment of warfarin (Coumadin) doses.
Ebell MH
Am Fam Physician; 2005 May; 71(10):1979-82. PubMed ID: 15926414
[No Abstract] [Full Text] [Related]
18. Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.
Sellam J; Costedoat-Chalumeau N; Amoura Z; Aymard G; Choquet S; Trad S; Vignes BL; Hulot JS; Berenbaum F; Lechat P; Cacoub P; Ankri A; Mariette X; Leblond V; Piette JC
Joint Bone Spine; 2007 Oct; 74(5):446-52. PubMed ID: 17692552
[TBL] [Abstract][Full Text] [Related]
19. Prevention of deep vein thrombosis. First choice treatments.
Prescrire Int; 2015 Sep; 24(163):217-9. PubMed ID: 26417635
[No Abstract] [Full Text] [Related]
20. Secondary prophylaxis with warfarin for venous thromboembolism.
Büller HR; Prins MH
N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
